MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 by Intellectual Property Watch 1 Comment Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically.
UNCTAD Shows Role As Convenor On Investment In Antimicrobial Resistance 30/10/2017 by William New, Intellectual Property Watch Leave a Comment The United Nations Conference on Trade and Development (UNCTAD) this month gathered a wide range of key stakeholders to have a frank discussion about how to solve rising global resistance to existing antibiotics. While not a negotiation, stakeholders in the expert group opened up and shared perspectives, leading to some informal conclusions. Among them: more public and private investment, and a shift in the R&D system to new-style incentives, are needed.
Reaping The Benefits Of Artificial Intelligence 26/10/2017 by Guest contributor for Intellectual Property Watch Leave a Comment Your brand is everything in the global marketplace. It is no exaggeration to say that a business now lives and dies by both its offline, online and social reputation. Because of this, searching a trademark is more vital than ever before. It is important for trademark professionals to work faster and more effectively in searching, clearing and registering strong marks to ensure clients have a competitive advantage. To do so requires the merging of the old and new: the specific knowledge that only highly experienced trademark experts can provide, with the advantages of the latest wave of artificial intelligence (AI) technology, writes Ronda Majure.
WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines.
No Progress On WTO Appellate Body Appointments As Ranks Thinning 25/10/2017 by Intellectual Property Watch 2 Comments The imbroglio which might cause a major impediment to the World Trade Organization’s functioning is thickening as the United States continues to block the selection process to fill vacancies in the WTO Appellate Body, according to sources.
CARB-X Makes Award For First Topical Antimicrobial; Could Be Used In Emergency Settings 24/10/2017 by Intellectual Property Watch Leave a Comment CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month of funding another firm to develop a new antibiotic class to treat drug-resistant Gram-negative bacterial infections.
Global Fund For AIDS, TB & Malaria Narrows Director Candidates To Four 23/10/2017 by William New, Intellectual Property Watch 1 Comment The Global Fund for AIDS, Tuberculosis and Malaria announced today it has narrowed the search to four high-level candidates, coming from backgrounds in banking, development agencies and United Nations programs.
Staff Union Welcomes Next EPO President, Hopes For Dialogue 23/10/2017 by Intellectual Property Watch Leave a Comment In a letter to its members, the Staff Union of the European Patent Office (SUEPO) in The Hague, Netherlands has welcomed the election of Antonio Campinos as new President of the EPO a week ago, expressed hope for a change in EPO management-workforce relations and has some recommendations for next steps.
WIPO Report To Annual Assemblies Contains Some Interesting Facts 20/10/2017 by William New, Intellectual Property Watch 1 Comment Among all the high-profile issues on the stage and the countless side meetings and cultural celebrations happening at the annual World Intellectual Property Organization annual Assemblies, there were some interesting facts and figures presented about the UN agency itself.
World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment BERLIN — With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area.